Solventum Corp | SOLV - Equity Capital And Reserves


Solventum Corp reported $4.81B in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
Abbott USD 51.03B 83M Sep/2026
Align Technology USD 4.23B 83.03M Jun/2026
Baxter International USD 6.5B 296M Sep/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Cencora USD 3.05B 346.63M Jun/2026
Dexcom USD 2.54B 86M Sep/2026
Insulet USD 1.58B 156.9M Sep/2026
Solventum Corp USD 4.81B 5M Sep/2026
West Pharmaceutical Services USD 2.97B 22M Sep/2026
Zimmer Biomet Holdings USD 12.72B 83.1M Sep/2026